Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

NCRI 2019 | Limitations of precision medicine to be addressed

Ian Tannock • 4 Nov 2019
NCRI 2019
General

Ian Tannock, MD, PhD, FASCO, University of Toronto, Toronto, Canada, highlights the limitations with precision medicine in cancer therapy. Recorded at the 2019 National Cancer Research Institute (NCRI) Annual Cancer Conference, in Glasgow, UK.
For more information about the NCRI Cancer Conference, visit https://conference.ncri.org.uk.

More from Ian Tannock

2:38
The thinking behind precision medicine for cancer therapy
Ian Tannock • 4 Nov 2019
3:57
The disadvantages of randomised clinical trials
Ian Tannock • 27 Jan 2017
1:14
Presenting your research – practical advice
Ian Tannock • 26 Jan 2017
3:38
Highlighting problems in personalized medicine
Ian Tannock • 26 Jan 2017

Related Videos

2:03
Biomarker detection for early cancer detection
Robert Rintoul • 19 Apr 2024
0:29
Innovative ctDNA-based liquid biopsy techniques for cancer diagnosis
Alain Thierry • 9 Apr 2024
0:50
Employing fragmentomics as a novel strategy to characterize and detect cancers
Alain Thierry • 9 Apr 2024
1:27
Emerging trials in melanoma: SWOG S1801, OpACIN-neo and PRADO
Christoffer Gebhardt • 9 Apr 2024
The content of VJOncology is intended for healthcare professionals